Cuban President Miguel Díaz-Canel Bermúdez congratulated today on Twitter the rector of the University of Havana (UH), Dr. Miriam Nicado, awarded Wednesday with the Cuban Academy of Sciences (ACC) Honorary Scholar distinction.

The timely identification of people with COVID-19 symptoms is one of the top priorities of health authorities in the province of Holguin, given the rise in the number of patients who evolve into severe forms of the disease.

 The over-60-year US economic, commercial and financial blockade has had a severe impact on the island’s health system calculated at 198 million 348 thousand dollars only between April and December 2020.

With the 1,019 positive cases of the SARS-CoV-2 coronavirus diagnosed on Monday, Cuba has accumulated in the first three days of May 3,022 patients infected with the virus that causes COVID-19, and 32 deaths from the disease, including the last 11, which shows that transmission and lethality remain high.

Jorge Luis Perdomo, Cuban deputy prime minister, toured today the facilities of the Center for Genetic Engineering and Biotechnology (CIGB) and Aica Laboratories, a company that produces generic injectable drugs, entities that lead the development and production of the Cuban anti-COVID-19 vaccine candidates.

Although in the start-up stage, the Laboratory of Cellular and Molecular Biology, in this city, is already carrying out diagnostic tests by PCR in real time to detect the SARS-CoV-2 virus.

Cuba studied 20,700 samples fpr COVID 19, resulting in 1,019 positive ones. The country accumulates 3,720,729 samples taken and 110,644 positive.

HAVANA, Cuba, May 4 (ACN) With 31,346 people diagnosed with COVID-19 in Cuba, April has been confirmed as the month with the highest number of positive cases of the disease since the epidemic began in the country in March 2020.

May 1st marked the end of the three-dose COVID-19 vaccination with very good results as to safety and immunogenicity of the Candidate vaccine ABDALA, said senior researcher heading the vaccination project Doctor Sonia Resik.

With the 932 new positive cases of SARS-CoV-2 coronavirus detected this Sunday in Cuba, there are now 109,625 people diagnosed with this disease, (2.96%) since the outbreak of the pandemic in the country, on March 11, 2020, announced today the ministry of public health ( MINSAP by its Spanish acronym).

Health professionals and the Center for Genetic Engineering and Biotechnology (CIGB) are assessing from today the efficacy of the Cuban anti-COVID-19 Abdala vaccine candidate, after concluding the application of the immunogen in the volunteers of the phase III clinical trial.

Cuba studied 22,938 samples for COVID 19, resulting in 932 positive ones. The country accumulates 3, 700,029 samples taken and 109,625 positive.

The National Coordinating Center for Clinical Trials (CENCEC) strives to keep complying with the Good Clinical Practices and to maintain its certification of its Quality Management System, in accordance with the requirements of the ISO 9001 Standard, a status it has held since 2008, granted by the National Bureau of Standards and AENOR International.

A project to determine the genetic predisposition of patients with Spinocerebellar Ataxia type II (SCA2) to become infected with COVID-19 is under way by specialists in this province, top of the list in prevalence of this disease in Cuba.